These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 187990)

  • 41. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human chorionic gonadotropin assays and their uses.
    Tyrey L
    Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum relaxin in patients with hydatidiform mole.
    Seki K; Uesato T; Tabei T; Kato K
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of persistent trophoblastic diseases based on a human chorionic gonadotropin regression curve by means of a stepwise piecewise linear regression analysis after the evacuation of uneventful moles.
    Shigematsu T; Kamura T; Saito T; Kaku T; Nakano H; Kinugawa N
    Gynecol Oncol; 1998 Dec; 71(3):376-80. PubMed ID: 9887234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of serum progesterone during treatment of malignant trophoblastic disease.
    Dawood MY
    Am J Obstet Gynecol; 1975 Oct; 123(3):291-8. PubMed ID: 170826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progesterone concentration in placenta, molar tissue, and ovarian theca lutein cyst.
    Dawood MY; Teoh ES; Das NP
    Obstet Gynecol; 1975 Feb; 45(2):171-4. PubMed ID: 163995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fluctuations of plasma progesterone, 17alpha-OH-progesterone and estrogens in trophoblastic diseases (author's transl)].
    Miyamoto T
    Nihon Naibunpi Gakkai Zasshi; 1977 Mar; 53(3):203-20. PubMed ID: 199477
    [No Abstract]   [Full Text] [Related]  

  • 50. Serum methotrexate and human chorionic gonadotropin concentrations during five-day chemotherapy for low-risk metastatic gestational trophoblastic neoplasia.
    Hilgers RD; Standefer JC; Bowling MC; Greeley P
    Int J Gynaecol Obstet; 1988 Dec; 27(3):421-5. PubMed ID: 2904909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma testosterone in molar pregnancy: Correlation with gestational age, uterine size, theca-lutein cyst and serum HCG.
    Chew PC; Ratnam SS; Goh HH
    Br J Obstet Gynaecol; 1978 Aug; 85(8):624-6. PubMed ID: 687543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Computed tomography of gestational trophoblastic disease.
    Davis WK; McCarthy S; Moss AA; Braga C
    J Comput Assist Tomogr; 1984 Dec; 8(6):1136-9. PubMed ID: 6094624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment.
    Dhillo WS; Savage P; Murphy KG; Chaudhri OB; Patterson M; Nijher GM; Foggo VM; Dancey GS; Mitchell H; Seckl MJ; Ghatei MA; Bloom SR
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E878-84. PubMed ID: 16757546
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The significance of serum progesterone and serum unconjugated oestradiol-17beta in unaborted hydatidiform mole.
    Dawood MY
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):729-39. PubMed ID: 169657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasound imaging after evacuation as an adjunct to beta-hCG monitoring in posthydatidiform molar gestational trophoblastic neoplasia.
    Garavaglia E; Gentile C; Cavoretto P; Spagnolo D; Valsecchi L; Mangili G
    Am J Obstet Gynecol; 2009 Apr; 200(4):417.e1-5. PubMed ID: 19200936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for persistent gestational trophoblastic neoplasia.
    Kuyumcuoglu U; Guzel AI; Erdemoglu M; Celik Y
    J Exp Ther Oncol; 2011; 9(1):81-4. PubMed ID: 21275269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha subunit and human chorionic gonadotropin in normal pregnancy and gestational trophoblastic disease.
    Elegbe RA; Pattillo RA; Hussa RO; Hoffmann RG; Damole IO; Finlayson WE
    Obstet Gynecol; 1984 Mar; 63(3):335-7. PubMed ID: 6199703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bilateral adnexal torsion due to postmenopausal hydatidiform mole.
    Özdemir S; Balcı O; Görkemli H; Koyuncu T; Turan G
    J Obstet Gynaecol Res; 2011 Apr; 37(4):359-62. PubMed ID: 21349123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperreactio luteinalis associated with pregnancy: a case report and review of the literature.
    Schnorr JA; Miller H; Davis JR; Hatch K; Seeds J
    Am J Perinatol; 1996 Feb; 13(2):95-7. PubMed ID: 8672193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum relaxin and steroid hormones in spontaneous abortions.
    Seki K; Uesato T; Tabei T; Kato K
    Acta Obstet Gynecol Scand; 1988; 67(6):483-6. PubMed ID: 3239380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.